Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Sales | 10,330 | 9,860 | 6,870 | 9,650 | 14,070 |
| Gross Profit | 10,330 | 9,860 | 6,870 | 9,650 | 14,070 |
| Operating Expenses | 24,720 | 20,860 | 24,500 | 23,930 | 22,680 |
| Operating Income | -14,390 | -11,000 | -17,630 | -14,280 | -8,610 |
| Interest Expense | 1 | 410 | 510 | 470 | 1,210 |
| Other Income | -1,729 | -22,580 | -1,050 | 500 | -5,010 |
| Pre-tax Income | -16,120 | -33,990 | -19,190 | -14,250 | -14,830 |
| Net Income Continuous | -13,979 | -10,844 | -17,489 | -14,379 | -14,833 |
| Net Income | $-16,120 | $-33,990 | $-19,190 | $-14,250 | $-14,830 |
| EPS Basic Total Ops | -6,862.75 | -24,299.72 | -15,406.16 | -12,605.04 | -18,207.28 |
| EPS Basic Continuous Ops | -5,824.58 | -7,745.71 | -14,574.17 | -13,071.82 | -18,541.25 |
| EPS Diluted Total Ops | -6,862.75 | -24,299.72 | -15,406.16 | -12,605.04 | -18,207.28 |
| EPS Diluted Continuous Ops | -5,824.58 | -7,745.71 | -14,574.17 | -13,071.82 | -18,541.25 |
| EBITDA(a) | $-13,790 | $-10,280 | $-16,320 | $-13,000 | $-6,190 |